Ok

By continuing your visit to this site, you accept the use of cookies. These ensure the smooth running of our services. Learn more.

Industry Updates - Page 22

  • Brain Health Supplements Market to experience growth by 2028

    March 09, 2023/Industry News Global/ -- This new report from Stratview Research analyses the Brain Health Supplements Market over the forecast period from 2022 to 2028. The insights of the report shall enable informed decision-making and strategy formulation for the near future to capitalize on the opportunities.

    Brain Health Supplements Market Overview:

    The brain health supplements market was estimated at US$ 8.23 billion in 2021 and is expected to grow at a CAGR of 8% during 2022-2028 to reach US$ ~17.40 billion in 2028.

    Drivers

    The following are the major players in the brain health supplements market:

    • AlternaScript
    • HVMN Inc.
    • Intelligent Labs
    • Natural Factors Nutritional Products Ltd.
    • NOW Foods
    • Onnit Labs, Inc.
    • Peak Nootropics
    • Purelife Bioscience Co., Ltd.
    • Reckitt Benckiser Group plc.
    • Teva Pharmaceutical Industries Ltd.

    Manufacturers have been concentrating on creating a range of supplements that are specifically aimed at athletes who place an emphasis on improving their performance and preserving their composure. Over the following few years, this is anticipated to increase demand for supplements supporting brain health.

    Segment Analysis

    The market is segmented based on supplement type, product, age group, application, distribution channel, and geography. On the basis of supplement type, the segment is divided into tablets, capsules, others.

    On the basis of product, the segment is divided into natural molecules, herbal extract, vitamins and minerals. In terms of global revenue for 2021, the natural molecule sector held the biggest market share and is predicted to continue to dominate. This market's expansion is anticipated to be aided by the growing preference for brain supplements manufactured from natural ingredients over synthetic ones. Companies are also emphasising the use of natural ingredients in their products.

    Based on age group, the market is segmented into children, adults, elderly.

    On the basis of application, the market is segmented into memory enhancement, attention and focus, depression and mood, sleep and recovery, anti-aging and longevity, stress & anxiety. In terms of global revenue in 2021, the memory improvement sector held the biggest market share and is predicted to continue to dominate. The millennial generation is engaging in a variety of activities outside of their primary occupation, such as adventure sports, social events, and part-time work, which needs them to be intellectually awake throughout the day. Therefore, it is anticipated that changing consumer habits will increase demand for these goods. A survey from the Organization for Economic Cooperation and Development indicates that part-time employment is becoming more prevalent in nations like Germany, Italy, France, and Austria. Over the projection period, the shift in consumer lifestyle is anticipated to increase demand for memory-boosting supplements.

    Based on distribution channel, the market is divided into supermarkets & hypermarkets, drug stores, online stores, and others.

    The brain health supplements market is broken down geographically into areas like North America, Europe, Asia-Pacific, and the Rest of the World (RoW). In 2021, North America contributed most to the market. The demand for the product in North America is being driven by consumers' increased concerns about their mental health. Nearly 75% of U.S. adults consume dietary supplements that contain vitamins, minerals, and herbal ingredients to enhance brain health, energy, and performance, according to statistics released by the U.S. National Library of Medicine in April 2020. These trends are probably going to accelerate the market expansion in the nation. In America, loneliness and uncertainty about the future are major stressors for adolescents and young adults, according to data published by the American Psychological Association in October 2020, which is expected to lead an increase in the number of adults to use brain health supplements for the right kind of treatment.

    Get access to a deeper coverage of the impact of COVID-19 on this Market here: https://www.stratviewresearch.com/Request-Sample/3114/brain-health-supplements-market.html#form

    About Stratview Research

    Stratview Research is a global market intelligence firm providing wide range of services including syndicated market reports, custom research and sourcing intelligence across industries, such as Advanced Materials, Aerospace & Defense, Automotive & Mass Transportation, Consumer Goods, Construction & Equipment, Electronics and Semiconductors, Energy & Utility, Healthcare & Life Sciences, and Oil & Gas.

    For enquiries,
    Contact:
    Stratview Research
    E-mail: 
    sales@stratviewresearch.com
    Direct: +1-313-307-4176

     

  • Bio-Composites Market Set for Rapid Growth During 2022-2027

    The Bio-Composites Market is Segmented by End-Use Type (Building and Construction, Automotive, Industrial and Consumer Goods, and Others), by Process Type (Extrusion, Compression Molding, Injection Molding, and Others), by Resin Type (Polyethylene, Polypropylene, Polyvinyl Chloride, Polylactic Acid, and Others), by Fiber Type (Wood Flour, Flax, Kenaf, Hemp, Jute, and Others), and by Region (North America, Europe, Asia-Pacific, and Rest of the World).

    What is a Bio-Composites Market?

    Bio-composite is basically a composite material which is formed by a matrix and a reinforcement of natural fibers. In this material, either one of the matrix and reinforcement components or both are from bio-based origins. Environmental concerns and the high cost of synthetic fibers have resulted in an increased utilization of natural fiber as reinforcement, which is likely to drive the bio-composites market in the coming years.

    Market Dynamics

    Bio-composites find various applications, ranging from household articles to automobiles, eventually resulting in an increased product demand. Growing demand for wood plastic composites in the construction industry and increasing utilization of natural fiber composites in automotive interiors are some of the key factors expected to drive the market growth during the forecast period. Overall, the bio-composites market is likely to rebound at a healthy CAGR of 3.5% during the forecast period.

    Get access to a deeper coverage of the impact of COVID-19 on this Market here:

    https://www.stratviewresearch.com/Request-Sample/3055/bio-composites-market.html#form

     

    Features of the Report

    This report offers high-quality insights and is the outcome of detailed research methodology comprising extensive secondary research, rigorous primary interviews with industry stakeholders and validation and triangulation with Stratview Research’s internal database and statistical tools.

    The Bio-Composites Market analysis report discusses the following heads in details:

    • Market structure: Overview, industry life cycle analysis, supply chain analysis.
    • COVID-19 Impact Assessment.
    • Market environment analysis: Growth drivers and constraints, Porter’s five forces analysis, SWOT analysis.
    • Market trend and forecast analysis.
    • Market segment trend and forecast.
    • Competitive landscape and dynamics: Market share, product portfolio, product launches, etc.
    • Attractive market segments and associated growth opportunities.
    • Emerging trends.
    • Strategic growth opportunities for the existing and new players
    • Key success factors.

    Regional Analysis

    In terms of regions, Asia-Pacific is estimated to be the largest as well as the fastest-growing region in the market for bio-composites during the forecast period with Japan, India and China being the growth engines of the region. Furthermore, growing demand for wood plastic composites decking, fencing, and railing in the building and construction industry is expected to accelerate the regional market growth over the forecast period.  

     

    Custom Research: Stratview research offers custom research services across sectors. In case of any custom research requirement related to market assessment, competitive benchmarking, sourcing and procurement, target screening, and others, please send your inquiry to sales@stratviewresearch.com.

     

  • Cancer Supportive Care Drugs Market: Revenue and growth prediction till 2026 with covid-19 impact analysis

    March 07, 2023/Industry News Global/ -- This new report from Stratview Research analyses the Cancer Supportive Care Drugs Market over the forecast period from 2022 to 2028. The insights of the report shall enable informed decision-making and strategy formulation for the near future to capitalize on the opportunities.

    Cancer Supportive Care Drugs Market Overview:

    The cancer supportive care drugs market was estimated at US$ 20.9 billion in 2021 and is expected to grow at a CAGR of 2.04% during 2022-2028 to reach US$ ~21.40 billion in 2028.

    Drivers

    The following are the major players in the cancer supportive care drugs market:

    • Amgen, Inc.
    • F. Hoffmann-La Roche Ltd.
    • GlaxoSmithKline plc (GSK)
    • Helsinn Healthcare SA
    • Heron Therapeutics, Inc.
    • Johnson & Johnson Services, Inc.
    • Merck & Co., Inc.
    • Novartis AG

    Rising technological and therapeutic developments as well as an increase in product launches by market participants are factors driving the growth of the global market for asthma and COPD medications. For the introduction of new products, certain governmental organisations work with industry participants.

    Segment Analysis

    Based on drug class, application, distribution channel, and geography, the market has been divided into segments. On the basis of drug class, the market has been segmented into G-CSFs (Granulocyte-colony Stimulating Factors), ESAs (Erythropoiesis Stimulating Agents), anti-emetics, bisphosphonates, opioids, NSAIDs, and others. The Granulocyte Colony Stimulating Factor (G-CSF) category had the highest revenue. It is the main option for treating neutropenia brought on by cancer. It is one of the most frequently prescribed supportive care medications for lymphoma and breast malignancies. For instance, in the UK, G-CSF is given to 84% of patients with lymphoma and 70% of breast cancer patients, respectively. However, the declining usage of myelosuppressive chemotherapy, which limits the formation of G-CSF, is a consequence of the increased use of immuno-oncology (IO) drugs in therapy, such as anti-PD-1/L1s. During the anticipated term, positive growth in the antiemetics segment is anticipated.

    Chemotherapy-induced nausea and vomiting (CINV) is one of the most frequent issues that patients with chemotherapy deal with. The introduction of more recent medications including Cinvanti, Sustol, and Varubi is to blame for the rise. However, the overall CINV medicines sales would be impacted by the patent expiry of important antiemetic medications like Emend. During the projection period, the growth of the opioid segment is anticipated to slow. Opioid medicines are subject to strict controls imposed by governments in many nations, including the US government. As a result, the rate of opioid medicine prescriptions has dramatically decreased.

    Based on application, the cancer supportive care drugs market has been divided into breast cancer, lung cancer, colorectal cancer, prostate cancer, liver cancer, stomach cancer, and others.

    On the basis of distribution channel, the market is segmented into hospital pharmacies, retail pharmacies, online pharmacies.

    The cancer supportive care drugs market is broken down geographically into areas like North America, Europe, Asia-Pacific, and the Rest of the World (RoW). The launch and quick adoption of biosimilars as well as curbs on the prescription of opioids are likely to cause the market in North America and other developed regions to contract over the course of the forecast period. Additionally, tailored, targeted medicines are widely used in these regions due to their lower incidence of adverse effects, increasing public knowledge of their availability, and supportive reimbursement practises for expensive targeted therapies. High unmet needs for cancer supportive care exist in developing nations such those in the Middle East and Africa, Latin America, and Asia-Pacific. Chemotherapy is still a common treatment because of the underdeveloped healthcare systems and low levels of disposable income in these areas. These elements are anticipated to fuel market expansion in these regions.

    Get access to a deeper coverage of the impact of COVID-19 on this Market here:https://www.stratviewresearch.com/Request-Sample/3140/cancer-supportive-care-drugs-market.html#form

    About Stratview Research

    Stratview Research is a global market intelligence firm providing wide range of services including syndicated market reports, custom research and sourcing intelligence across industries, such as Advanced Materials, Aerospace & Defense, Automotive & Mass Transportation, Consumer Goods, Construction & Equipment, Electronics and Semiconductors, Energy & Utility, Healthcare & Life Sciences, and Oil & Gas.

    For enquiries,
    Contact:
    Stratview Research
    E-mail: 
    sales@stratviewresearch.com
    Direct: +1-313-307-4176